Optibiotix Health Share Discussion Threads

[someuwin] 07/9/2017 07:27

Stephen O'Hara, CEO of OptiBiotix, commented: "This invitation shows that OptiBiotix is being increasingly regarded as a key player in microbiome science and industrial biotechnology. The interest in our OptiScreen(R) and OptiBiotic(R) platforms suggests that the industry believes we are developing commercially-attractive products that will need to be manufactured at an industrial scale in the near future. We are very excited to take part and feel very honoured and thankful to the organisers for considering us."

[rafboy] 07/9/2017 07:22

Another great piece of news this morning. OPTI being invited to present in Spain amounts to international recognition of how important our science and products are.

[shrewdmole] 07/9/2017 06:50

Elrico

Your last post is spot on.

When they announced Sacco I did suggest that was the last piece of the jigsaw required for the big boys to sign.

They would have needed assurances that the product could be manufactured and supplied in very large scale.

I also think that's how soh got such a good deal with Sacco as he would have said look I have p and g etc queuing up for this but I need someone to manufacture! I'm sure he will have used that stick!

Anyway it would suggest a more rapid news flow on more deals.

Keep up the good work.

S

[neftanikoff] 07/9/2017 06:35

7 September 2017

OptiBiotix Health plc

OptiBiotix invited to present at Expoquimia in Barcelona

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, announces it has been invited to present its research and commercial developments at the 18th edition of Expoquimia-World Chemical Summit (‘Expoquimia’) in Barcelona, Spain, on 5 October 2017.

Expoquimia is a multidisciplinary event held triennially in which the industry, professional associations, governments and academia come together to discuss future opportunities and challenges in industrial chemistry and biotechnology. In its previous edition, it had over 600 exhibitors and 38,000 visitors, making it one of the largest industrial chemistry events in Europe.

The Company will present the presentation titled: ‘New approaches: microbiome modulation as therapeutic intervention’, which will provide an overview of the wide array of existing strategies to modulate the microbiome to support human health, with a special focus on OptiBiotix’s technology platforms for the development of novel prebiotics and probiotics.

Stephen O’Hara, CEO of OptiBiotix, commented: “This invitation shows that OptiBiotix is being increasingly regarded as a key player in microbiome science and industrial biotechnology. The interest in our OptiScreen® and OptiBiotic® platforms suggests that the industry believes we are developing commercially-attractive products that will need to be manufactured at an industrial scale in the near future. We are very excited to take part and feel very honoured and thankful to the organisers for considering us.”

[tony773] 07/9/2017 06:27

I honestly do not think us buying the 40, 50,000 shares make a difference when we get the big funds coming in, or even the little ones, they will make a difference and the share price should power ahead, 100p by Xmas will be good

[incanus] 06/9/2017 22:12

ferdinand, i hadnt thought about the 4 way split valuation, it does demonstrate how cheap opti is. Eye opener for me.

[trotterstrading] 06/9/2017 22:09

I've said it many times before, the secret to OPTI's success will be SoH. Quite frankly the guy is a genius, the brightest and most business savvy CEO I've ever met, and I've met plenty in 20 years plus investing. Take a moment to stop and think what he has created, Slimbiome, LP LDL, sweetbitox, the SBTX IPO and more. It's simple, there is no one I trust more with my money

[parob] 06/9/2017 22:07

Makes me think there's a good chance Tata could be the first partner for SweetBiotix.

[parob] 06/9/2017 21:47

Tata are super-keen on the microbiome. An article from 2016:Tata Group tying up with Harvard and Yale for research; sets aside $25 millionhTTp://economictimes.indiatimes.com/news/company/corporate-trends/tata-group-tying-up-with-harvard-and-yale-for-research-sets-aside-25-million/articleshow/53923718.cmsPart of the tie-up with Yale will also be focussed on research into the gut microbiome - the term used for the interactions between the different kinds of microorganisms that live in the human intestinal system that can affect human health. Tata Global Beverages and Tata Chemicals are both interested in nutraceuticals." For example, Tata Global Beverages is interested in vitamins and other aspects of making drinks healthier," Katragadda said. Tata Chemicals has already launched its first nutraceutical product. ---------------Of course with OPTI, the research has already been done. Partnering with them speeds up the whole process.

[onedayrodders] 06/9/2017 21:26

So hopefully this side of xmas an RNS will drop confirming the mighty TATA are launching a range of Slimbiome products in ASIA

:o)

[jambam] 06/9/2017 21:10

people don't also realise that OPTI would get a lot more than the current valuation for selling their LDL strain. Not that they would.

[f3rdinand] 06/9/2017 20:57

I think this is what outside observers are missing with OPTI! They see a £60 million valuation and try to justify it based on current revenues! However, OPTI really is four companies in one and not just any old companies! Weight loss, cholesterol/ bp reduction, healthy sugars and skincare.They each have access to billion pound markets and are at the forefront of cutting edge science globally!Take our current market value and divide it by four you get an average £15 million valuation for each area. To me that is crazily cheap for the sheer potential each division has!

[riskybusiness1] 06/9/2017 19:51

From the results:OPTIBIOTICS®, MICROBIOME MODULATION, AND SWEETBIOTICS® OptiBiotix has made significant progress in its scientific programmes to develop compounds which modify the human microbiome to prevent, manage and treat disease. These now cover three areas and is a substantive opportunity in its own right:- • Microbiome modulators where OptiBiotix® has demonstrated its ability to manipulate both the microbiome's composition and its function. These ingredients are heat resistant and stable during processing, which creates the opportunity to incorporate low cost, safe ingredients which modulate specific elements of the microbiome in a wide range of food products. This creates the potential for designer ingredients, supplements and food products which can modify an individual's current microbiome to improve health. In the last six months, we have extended our work into other microbial general associated with health benefits directly, or through the production of bioactives, like short chain fatty acids (SCFA's)• Combining microbiome modulators with existing products such as probiotics to greatly enhance the products health benefits. Our teams have demonstrated that by combining our cholesterol reducing strain, LPLDL®, with galacto-oligosaccharides produced from it, we can selectively enhance its growth and increase cholesterol reduction threefold. Work in the last six months has extended these developments to other probiotic genera and species. To the best of our knowledge, this is the first time that anyone has developed an optimised synbiotic, or OptiBiotic®, that increases the growth and health benefit of a specific bacterium in the microbiome. We see the development of species or genera specific prebiotics which can selectively enhance the growth and health benefits of existing probiotic products as a growing area of interest to the probiotic industry, a market expected to be worth more than $46.5bn by 2020 (Markets and Markets)• SweetBiotix® - The SweetBiotix® concept is an innovative concept with the potential to address a global requirement, addressing international concerns over the impact of sugar on obesity, with the prospect of replacing 'unhealthy' sugars in existing products with non-digestible, low calorie, healthy, SweetBiotix®. These sweet natural healthy sugars are not digested in the human gut and hence calorie free. In the last six months, we have accelerated our development programmes in this area with independent human studies of six customised oligosaccharides developed from high intensity natural sweeteners showing sweetness of between 140X and 223X that of sucrose at equivalent concentrations, with a large reduction in bitterness when compared to Stevia. This has stimulated high industry interest and we anticipate further developments and announcements in this area in the future. Point one is the deal with TATA, point 2 with DSM and Sweetbiotix just coming through studies. Three seperate applications. 'Multiple products multiple partners multiple opportunities' they just all happen to be going to plan and are each huge opportunities in their own right.

[elrico] 06/9/2017 18:07

An afterthought...we now know SACCO held up the signature for four weeks post Vitafoods because the owner was on his jollies, which means August 22nd was official announcement. SACCO have been instrumental in the pace LP-LDL related deals have been concluded, TATA appears to be a prime example of this. I don't think it's a coincidence TATA was announced yesterday within weeks of SACCO concluding the global signature with OPTI. My guess is we will now start to see a multiple of national deals coming through and at any time we could have TATA/SlimBiome announcement. I would imagine we are getting very close to the inflection point, which may be assisted by the Las Vegas exhibition with SACCO, who already have a number of clients lined up wanting to use OPTI's LP-LDL. In terms of share price, I see very little negative and it we get revenue figures we could then see a big spike up, but until then, small incremental rises is good from here.

Thank you all for you encouragement, PM's and emails, they are appreciated and makes the work more rewarding.

[siennadelekat21] 06/9/2017 17:46

Another great bit of work by Elrico for the benefit of us all.... many thanks : )Sienna

[marnewton] 06/9/2017 17:21

It wasn't just me then?

Though I've seen perkier page 3s;¬)

M

[malreid] 06/9/2017 17:05

Elrico - absolutely fantastic work - many thanks for all your contributions. Don't know if I'd still be here without the confidence from your postings

[elrico] 06/9/2017 16:46

Sorry LUKE, I thought I found them all ;)

Page 3 sorted.

hxxps://goo.gl/DKVjun

[judijudi] 06/9/2017 16:13

Fantastic work elrico
Despite the grammatical errors and spelling mistakes!! :) :)

[primal123] 06/9/2017 15:33

Well done Elric, great work as usual! Fantastic read and it's really encouraging that we have a second deal with TATA! The slimbiome deal should hopefully be announced soon!

[neftanikoff] 06/9/2017 15:30

congrats elrico, as with everyone else

[elrico] 06/9/2017 15:14

I look forward to sinking a few with you, Slarty. Don't forget your costume, it's obligatory....compulsory to you ;)

Wearing a Chelsi shirt is not classed as fancy dress, either!

It's not selfless, I have an invested interest, like other here, as do my Children. Notwithstanding, there is nothing out there that excites, so I get a real joy from it.

See you soon dude.

[slartybartfaster] 06/9/2017 15:04

I wonder how many investors elrico has gave confidence in holding or adding in times of slippage. I hold my hands up, i almost buckled had it not been for he's tireless and selfless work. Cracking spot with the tata deal, i missed it.

Big big thank to you elrico. A few beers at HRH in november for sure.

[vanduke] 06/9/2017 14:54

Elrico.He the man...Thank you

[parob] 06/9/2017 14:49

Cheers Elrico!Now are we going to have a late afternoon push...